Abstract:Objective: The aim: To determine the diagnostic value of non-invasive methods of GERD diagnosis based on questionnaire data and a diagnostic test with a proton pump inhibitor (PPI) with Rabeprazole in patients with coronary heart disease (CHD). Patients and methods: Materials and methods: 90 patients were under observation, namely, 68 patients with coronary heart disease with concomitant essential arterial hyperten¬sion (EAH), 6 patients with coronary artery disease + arrhythmias, and 18 - others diseases. All patients were surveyed according to the GerdQ questionnaire, followed by PPI testing with Rabeprazole, and body mass index (BMI) was calculated for all the patients. A BMI of 18.5-24.9 kg/m2 was considered as normal body weight, and a BMI > 24.9 kg/m2 was considered overweight. Results: Results: Based on the results of the questionnaire, it was established that the most common complaints typical for GERD were noted by patients with CHD in combination with EAH. There were 48 of such patients and, depending on BMI, they were divided into 2 groups: 1st group (n=14) - patients with CHD+EAH+GERD with normal body weight and 2nd group (n=34) - overweight patients with CHD+EAH+GERD. In patients of group 1, typical symptoms of GERD prevailed (in 71.4% of patients), and in patients group 2, the distribution of typical and extra-esophageal symptoms did not differ significantly (52.9% vs. 47.1%). Among the extraesophageal manifestations, pain behind the sternum (in the projection of the esophagus) was significantly more often recorded in patients of group 1, and rhythm disturbances in patients of group 2 (43.8% and 75.0% of patients, respectively, p<0.05). The results of the GerdQ questionnaire showed a direct relationship between GERD, body weight and symptom score. Patients with GERD+normal body weight had a mean score of 6 for classic gastroesophageal reflux symptoms, while patients with GERD+increased body weight had a mean score of 7. The sensitivity of the questionnaire was 78.7%, and the specificity - 92.9%. According to the PPI test, in the 1st and 2nd groups, already in the first three days, 28.5% and 23.5% of patients noted the disappearance of heartburn and after 10 days - 85.7% and 64.7%, respectively. Over the entire period, that is, after 14 days of observation, 85.7% of patients in the 1st group and 73.5% in the 2nd group noted improvement. Conclusion: Conclusions: It has been established that questionnaires based on the GerdQ questionnaire followed by a PPI test with Rabeprazole in patients with coronary heart disease combined with essential arterial hypertension have a high diagnostic value and can be used for early diagnosis and effective treatment of GERD.

Prolonged acid reflux monitoring using acid exposure time and DeMeester score: two days are not enough

Comparing 3-Hour Ph Monitoring in Esophagus with 24-Hour Ph Monitoring to Diagnose GERD.

Comparison between 8-hour pH monitoring test in gastroesophageal reflux disease and 24-hour pH monitoring.

3h pH monitoring in esophagus for diagnosing gastroesophageal reflux disease

[Diagnostic Values of GerdQ, 24-H Ambulatory Oesophageal Ph and Impedance-Ph Monitoring in Barrett's Esophagus, Reflux Esophagitis and Non-Erosive Reflux Disease].

Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial

Analysis of 36 Cases of Refractory Gastroesophageal Reflux Disease with Impedance-pH Monitoring

[Extraesophageal reflux. Overview and discussion of a new method for pH monitoring]

Implementation of Objective Activity Monitoring to Supplement the Interpretation of Ambulatory Esophageal Ph Investigations

pHoenix score: development and validation of a novel approach to decrease the number of inconclusive GERD diagnoses

Relationship among Symptoms, Mucosal Injury, and Acid Exposure in Gastroesophageal Reflux Disease

An Analysis of 342 Patients with Refractory Gastroesophageal Reflux Disease Symptoms Using Questionnaires, High-Resolution Manometry, and Impedance-Ph Monitoring.

Sedation and Afternoon Placement of the 48-Hour Wireless Ambulatory pH Capsule Results in More Reflux on the First Day

[Clinical Value of 24-Hour Ph Monitoring in Patients with Laryngopharyngeal Reflux Disease].

NON-INVASIVE METHODS OF DIAGNOSTICS OF GASTRO-ESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH ISCHEMIC HEART DISEASE

Utility of mean nocturnal baseline impedance and post‐reflux swallow‐induced peristaltic wave index in clinical pH‐impedance reflux study

In vitro and in vivo evaluation of a novel wired transmission pH-combined photographic catheter for ambulatory gastroesophageal reflux monitoring (with videos)

The value of 24-hour multichannel intraluminal esophageal impedance-pH monitoring in differentiating NERD and functional heartburn patients

Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough

Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease.

Risk Factors for Refractory Gastroesophageal Reflux Disease